|Bid||144.20 x 800|
|Ask||144.22 x 800|
|Day's range||142.81 - 145.61|
|52-week range||91.21 - 146.26|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||46.36|
|Earnings date||29 Apr 2020 - 03 May 2020|
|Forward dividend & yield||0.80 (0.56%)|
|Ex-dividend date||15 Apr 2020|
|1y target est||149.09|
Zoetis acquires Ethos Diagnostic Science, a veterinary reference lab business, to further expand its comprehensive diagnostics capabilities.
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.